Sunday, September 24, 2023
As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.
Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
Professor of Pediatrics and Pathology
University of Michigan
Ann Arbor, Michigan, United States
Professor
Department of Pathology and Molecular Medicine
Queen's University
Kingston, Ontario, Canada
Associate Member
Director of Clinical Hematology
Director
Pediatric Hemophilia Treatment Center
Department of Hematology
St. Jude Children's Research Hospital
Memphis, Tennessee, United States
This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.
This activity is intended for hematologists, pediatricians, and other healthcare professionals who manage patients with hemophilia.
The goal of this activity is to discuss the evolution of gene therapy, including its development, ongoing research, and current and future uses, as well as how it may be used in hemophilia in the future.
Upon completion of this activity, participants will:
As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.
Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
Professor of Pediatrics and Pathology
University of Michigan
Ann Arbor, Michigan, United States
Professor
Department of Pathology and Molecular Medicine
Queen's University
Kingston, Ontario, Canada
Associate Member
Director of Clinical Hematology
Director
Pediatric Hemophilia Treatment Center
Department of Hematology
St. Jude Children's Research Hospital
Memphis, Tennessee, United States
This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.
Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Medscape, LLC staff have disclosed that they have no relevant financial relationships.
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print
out the tally as well as the certificates from the CME/CE Tracker.
*The credit that you receive is based on your user profile.
CME / ABIM MOC Released: 6/25/2018
Valid for credit through: 6/25/2019, 11:59 PM EST
processing....
The goal of this activity is to discuss the evolution of gene therapy, including its development, ongoing research, and current and future uses, as well as how it may be used in hemophilia in the future.
Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.
Presented through a collaboration between the National Hemophilia Foundation (NHF), European Haemophilia Consortium (EHC),
World Federation of Hemophilia (WFH), and Medscape Education.
Disclaimer
The educational activity presented above may involve simulated case-based scenarios. The patients depicted in these scenarios are fictitious and no association with any actual patient is intended or should be inferred.
The material presented here does not necessarily reflect the views of Medscape, LLC, or companies that support educational programming on medscape.org. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.
Medscape Education © 2018
Medscape, LLC
